Figure 2.

Summary of safety assessments with the intradermal and adjuvanted vaccines on days 0-7 post-vaccination. (a) Incidence of all and of severe solicited injection-site reactions. (b) Incidence of solicited systemic reactions

Van Damme et al. BMC Infectious Diseases 2010 10:134   doi:10.1186/1471-2334-10-134
Download authors' original image